SHVI Virtual Journal Club: Cardiovascular Risk Reduction with Icosapent Ethyl

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Physicians & APPs

Description

The pre-selected, peer-reviewed journal has been evaluated and reviewed for its importance by Drs. Jorge Alegria, Sanjeev Gulati, Richard Musialowski, Geoff Rose and Jai Singh. Readings should take no more than 25-35 minutes to complete. The video is a 15-20 minute interview-style discussion between one of the four directors and our local experts. The MOC questions are designed to assess your comprehension of the material and provide additional feedback regarding the topic. Overall, this activity should take approximately an hour to complete.

Speakers
Jorge Alegria, MD
Cheryl Russo, MD

Release Date: December 1, 2019
Valid Thru: November 30, 2021

Accreditation Statement
Atrium Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement
Atrium Health designates this Other (Journal Club and Internet Enduring Material) activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CME MOC

Have questions? Contact Carolyn Wilson at 704-446-2464 or via email Carolyn.Wilson@atriumhealth.org or click here.

Directions for accessing the journal article(s) are included in the module.

Objectives

  • Recognize the importance of review of current literature.
  • Apply critical evaluation to a current journal article.
  • Demonstrate the newest and most current beyond accepted guidelines.
  • Evaluate the guidelines of primary and secondary prevention of CAD
  • Evaluate the role of a novel agent in the management of triglycerides for primary and secondary CAD prevention
  • Integrate a novel agent into daily practice of dyslipidemia

Contact

Carolyn Wilson, Business Management, 704-446-2464

Electives

12/01/2019 - 11/30/2022
12:00 AM - 11:55 PM
Status
Open
Presenter(s)
Dr. Jorge R Alegria, MD, FACC, FASE,Dr. Cheryl Russo, MD
Date(s)
Dec 1, 2019 - Nov 30, 2022
Check-In Time
12:00 AM
Credit
1.00 - AMA PRA Category 1 Credit
1.00 - ABIM MOC
Location
Online Learning
Details
Status
Open
Date(s)
Dec 1, 2019 - Nov 30, 2021
Location
Online Learning
Fees
$0.00
Registration
Credits
1.00
ABIM MOC
1.00
AMA PRA Category 1 Credit